Literature DB >> 23507173

Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial.

Corrie M Whisner1, Berdine R Martin, Margriet H C Schoterman, Cindy H Nakatsu, Linda D McCabe, George P McCabe, Meryl E Wastney, Ellen G H M van den Heuvel, Connie M Weaver.   

Abstract

Adolescence is a time for rapid growth that represents an opportunity to influence peak bone mass. Prebiotic agents, such as galacto-oligosaccharides (GOS), increase Ca absorption in animal models and postmenopausal women. The objectives of the present study were to investigate the dose-response relationship of GOS supplementation on Ca absorption during growth and to assess changes in colonic microbiota to better understand the mechanism by which GOS is acting. A total of thirty-one healthy adolescent girls aged 10-13 years consumed smoothie drinks twice daily with 0, 2·5 or 5 g GOS for three 3-week periods in a random order. Fractional Ca absorption was determined from urinary Ca excretion over 48 h at the end of each 3-week period using a dual stable isotope method. Faecal microbiota and bifidobacteria were assessed by PCR-denaturing gradient gel electrophoresis and quantitative PCR. Fractional Ca absorption after the 48 h treatment with control, 5 and 10 g GOS/d was 0·393 (SD 0·092), 0·444 (SD 0·086) and 0·419 (SD 0·099), respectively. Significant improvements in Ca absorption were seen with both low and high doses of GOS compared with the control (P,0·02), but itwas not a dose-response relationship. The increase in absorption was greatest in the urine collected after 24 h, which is consistent with lower gut absorption. Faecal bifidobacteria increased (control 10·89 (SD 13·86), 5 g GOS 22·80 (SD 15·74) and 10 g GOS 11·54 (SD 14·20)) with the GOS treatment (P,0·03). The results suggest that daily consumption of 5 g GOS increases Ca absorption, which may be mediated by the gut microbiota, specifically bifidobacteria.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507173     DOI: 10.1017/S000711451300055X

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  37 in total

Review 1.  Probiotics, prebiotics and synbiotics- a review.

Authors:  Kavita R Pandey; Suresh R Naik; Babu V Vakil
Journal:  J Food Sci Technol       Date:  2015-07-22       Impact factor: 2.701

Review 2.  [Gut microbiota and osteoporosis].

Authors:  Yong-Quan Huang; Tao Jiang; Hai-Tao Su; Yi-Wen Luo; Qiu-Ke Hou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

Review 3.  Using stable isotope tracers to study bone metabolism in children.

Authors:  Kimberly O O'Brien; Steven A Abrams
Journal:  J Physiol       Date:  2018-07-17       Impact factor: 5.182

Review 4.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

5.  Bioactive foods and ingredients for health.

Authors:  Connie M Weaver
Journal:  Adv Nutr       Date:  2014-05-14       Impact factor: 8.701

Review 6.  Osteoimmunology: from mice to humans.

Authors:  Patrizia D'Amelio; Francesca Sassi
Journal:  Bonekey Rep       Date:  2016-05-18

Review 7.  Dietary fibre in gastrointestinal health and disease.

Authors:  Samantha K Gill; Megan Rossi; Balazs Bajka; Kevin Whelan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-18       Impact factor: 46.802

8.  Protective effects of α-galacto-oligosaccharides against a high-fat/western-style diet-induced metabolic abnormalities in mice.

Authors:  Zhuqing Dai; Simin Feng; Anna B Liu; Hong Wang; Xiaoxiong Zeng; Chung S Yang
Journal:  Food Funct       Date:  2019-06-19       Impact factor: 5.396

9.  Effect of soluble corn fiber supplementation for 1 year on bone metabolism in children, the MetA-bone trial: Rationale and design.

Authors:  C Palacios; M A Trak-Fellermeier; C M Pérez; F Huffman; Y Hernandez Suarez; Z Bursac; T B Gambon; C H Nakatsu; C M Weaver
Journal:  Contemp Clin Trials       Date:  2020-06-20       Impact factor: 2.226

Review 10.  The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.

Authors:  C M Weaver; C M Gordon; K F Janz; H J Kalkwarf; J M Lappe; R Lewis; M O'Karma; T C Wallace; B S Zemel
Journal:  Osteoporos Int       Date:  2016-02-08       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.